Shenzhen Chipscreen Biosciences Co.,Ltd. Posted 116 Million Yuan Net Profit in First Half of 2023

Shenzhen Chipscreen Biosciences Co.,Ltd. (深圳微芯生物科技股份有限公司) (688321.SH) reported a net profit of 116 million yuan in the first half of 2023, reversing a net loss of 19.3 million yuan for the same period in the previous year.

Meanwhile, the company posted 241.6 million yuan in revenue, up 11.9% year-on-year.

At the end of the reporting period, it had 3.2 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 43.7%.